BRIEF-ADC Therapeutics Announces Amended Healthcare Royalty Financing Agreement

Reuters

Feb 23

BRIEF-ADC <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Amended Healthcare Royalty Financing Agreement

Feb 23 (Reuters) - ADC Therapeutics SA ADCT.N:

ADC THERAPEUTICS ANNOUNCES AMENDED HEALTHCARE ROYALTY FINANCING AGREEMENT
ADC THERAPEUTICS SA - AGREEMENT REDUCES CHANGE OF CONTROL PAYMENT TO $150 MILLION THROUGH 2027
ADC THERAPEUTICS SA - HEALTHCARE ROYALTY GRANTED WARRANTS TO PURCHASE ABOUT 9.8 MILLION COMMON SHARES, WITH EXERCISE PRICE OF $3.81 PER SHARE
ADC THERAPEUTICS SA - ANTICIPATE MEANINGFUL GROWTH BEGINNING 2027, POTENTIAL PEAK REVENUE IN US COULD REACH $600 MILLION TO $1 BILLION ANNUALLY
ADC THERAPEUTICS SA - IN EVENT OF CHANGE OF CONTROL, HEALTHCARE ROYALTY WILL CONTINUE TO RECEIVE ROYALTIES BY ACQUIRER UNTIL ORIGINAL CAP IS REACHED

Source text: ID:nPn2D9yHSa

Further company coverage: ADCT.N

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2613781737"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2613781737\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2613781737?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-23 20:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2613781737","market":"us","top_or_hot":-1,"title":"BRIEF-ADC Therapeutics Announces Amended Healthcare Royalty Financing Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-ADC <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announces Amended Healthcare Royalty Financing Agreement</title></head><body><p><span>Feb 23 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ADCT\">ADC Therapeutics SA</a> <span>ADCT.N</span>:</p><ul><li><p>ADC THERAPEUTICS ANNOUNCES AMENDED HEALTHCARE ROYALTY FINANCING AGREEMENT</p></li><li><p>ADC THERAPEUTICS SA - AGREEMENT REDUCES CHANGE OF CONTROL PAYMENT TO $150 MILLION THROUGH 2027</p></li><li><p>ADC THERAPEUTICS SA - HEALTHCARE ROYALTY GRANTED WARRANTS TO PURCHASE ABOUT 9.8 MILLION COMMON SHARES, WITH EXERCISE PRICE OF $3.81 PER SHARE</p></li><li><p>ADC THERAPEUTICS SA - ANTICIPATE MEANINGFUL GROWTH BEGINNING 2027, POTENTIAL PEAK REVENUE IN US COULD REACH $600 MILLION TO $1 BILLION ANNUALLY</p></li><li><p>ADC THERAPEUTICS SA - IN EVENT OF CHANGE OF CONTROL, HEALTHCARE ROYALTY WILL CONTINUE TO RECEIVE ROYALTIES BY ACQUIRER UNTIL ORIGINAL CAP IS REACHED</p></li></ul><p>Source text: <span>ID:nPn2D9yHSa</span></p><p>Further company coverage: <span>ADCT.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-ADC Therapeutics Announces Amended Healthcare Royalty Financing Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-ADC Therapeutics Announces Amended Healthcare Royalty Financing Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-23 20:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-ADC <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announces Amended Healthcare Royalty Financing Agreement</title></head><body><p><span>Feb 23 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ADCT\">ADC Therapeutics SA</a> <span>ADCT.N</span>:</p><ul><li><p>ADC THERAPEUTICS ANNOUNCES AMENDED HEALTHCARE ROYALTY FINANCING AGREEMENT</p></li><li><p>ADC THERAPEUTICS SA - AGREEMENT REDUCES CHANGE OF CONTROL PAYMENT TO $150 MILLION THROUGH 2027</p></li><li><p>ADC THERAPEUTICS SA - HEALTHCARE ROYALTY GRANTED WARRANTS TO PURCHASE ABOUT 9.8 MILLION COMMON SHARES, WITH EXERCISE PRICE OF $3.81 PER SHARE</p></li><li><p>ADC THERAPEUTICS SA - ANTICIPATE MEANINGFUL GROWTH BEGINNING 2027, POTENTIAL PEAK REVENUE IN US COULD REACH $600 MILLION TO $1 BILLION ANNUALLY</p></li><li><p>ADC THERAPEUTICS SA - IN EVENT OF CHANGE OF CONTROL, HEALTHCARE ROYALTY WILL CONTINUE TO RECEIVE ROYALTIES BY ACQUIRER UNTIL ORIGINAL CAP IS REACHED</p></li></ul><p>Source text: <span>ID:nPn2D9yHSa</span></p><p>Further company coverage: <span>ADCT.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA6G5TKV:1","article_id":"2613781737","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2613781737","pubTimestamp":1771849734,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-ADC Therapeutics Announces Amended Healthcare Royalty Financing AgreementFeb 23 (Reuters) - ADC Therapeutics SA ADCT.N:ADC THERAPEUTICS ANNOUNCES AMENDED HEALTHCARE ROYALTY FINANCING AGREEMENTAD","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ADCT":"ADC Therapeutics SA","BK4505":"高瓴资本持仓"},"translate_title":"简报-ADC Therapeutics宣布修订医疗特许权使用费融资协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADCT":0.9},"content_text":"BRIEF-ADC Therapeutics Announces Amended Healthcare Royalty Financing AgreementFeb 23 (Reuters) - ADC Therapeutics SA ADCT.N:ADC THERAPEUTICS ANNOUNCES AMENDED HEALTHCARE ROYALTY FINANCING AGREEMENTADC THERAPEUTICS SA - AGREEMENT REDUCES CHANGE OF CONTROL PAYMENT TO $150 MILLION THROUGH 2027ADC THERAPEUTICS SA - HEALTHCARE ROYALTY GRANTED WARRANTS TO PURCHASE ABOUT 9.8 MILLION COMMON SHARES, WITH EXERCISE PRICE OF $3.81 PER SHAREADC THERAPEUTICS SA - ANTICIPATE MEANINGFUL GROWTH BEGINNING 2027, POTENTIAL PEAK REVENUE IN US COULD REACH $600 MILLION TO $1 BILLION ANNUALLYADC THERAPEUTICS SA - IN EVENT OF CHANGE OF CONTROL, HEALTHCARE ROYALTY WILL CONTINUE TO RECEIVE ROYALTIES BY ACQUIRER UNTIL ORIGINAL CAP IS REACHEDSource text: ID:nPn2D9yHSaFurther company coverage: ADCT.N ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}